Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients.
微转移衍生模型可用于对早期高危黑色素瘤患者进行药物测试。
期刊:EMBO Molecular Medicine
影响因子:8.3
doi:10.1038/s44321-025-00339-8
Weidele Kathrin, Werno Christian, Treitschke Steffi, Botteron Catherine, Hoffmann Martin, Scheitler Sebastian, Wöhrl Lukas, Czyz Zbigniew, Feliciello Giancarlo, Weber Florian, Ravikumar Varadarajan Adithi, Warfsmann Jens, Materna-Reichelt Silvia, Katzer Marie, Schreieder Laura, Mohammadi Parvaneh, Hosseini Hedayatollah, Honarnejad Kamran, Haferkamp Sebastian, Werner-Klein Melanie, Klein Christoph A